These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 7980021

  • 1. [Effects of platelet activating factor on release of thromboxane B2 from human granulocytes and platelets].
    Imai T, Horikoshi S, Kurokawa M, Idaira K, Mita S, Adachi M, Okamoto M.
    Arerugi; 1994 Jul; 43(7):809-14. PubMed ID: 7980021
    [Abstract] [Full Text] [Related]

  • 2. Platelet-activating factor stimulates arachidonic acid release and enhances thromboxane B2 production in intact fetal rat brain ex vivo.
    Kunievsky B, Yavin E.
    J Pharmacol Exp Ther; 1992 Nov; 263(2):562-8. PubMed ID: 1432689
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Influence of prostaglandins and PG-analogues on the mortality of PAF-acether in mice and the TXB2 release from human granulocytes.
    Becker K, Förster W.
    Biomed Biochim Acta; 1988 Nov; 47(10-11):S169-72. PubMed ID: 3248104
    [Abstract] [Full Text] [Related]

  • 5. Platelet-activating factor-induced human eosinophil activation. Generation and release of cyclo-oxygenase metabolites in human blood eosinophils from asthmatics.
    Kroegel C, Matthys H.
    Immunology; 1993 Feb; 78(2):279-85. PubMed ID: 8473016
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. At low extracellular calcium concentration platelet activating factor induces beta-thromboglobulin release from human platelets through thromboxane-endoperoxides formation.
    Zatta A, Zanetti A, Dejana E, Prosdocimi M.
    Agents Actions; 1987 Oct; 22(1-2):151-8. PubMed ID: 2961218
    [Abstract] [Full Text] [Related]

  • 8. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
    Porta C, Maiolo A, Tua A, Grignani G.
    Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
    [Abstract] [Full Text] [Related]

  • 9. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G, Block HU, Till U.
    Biomed Biochim Acta; 1984 Aug; 43(8-9):S323-6. PubMed ID: 6440547
    [Abstract] [Full Text] [Related]

  • 10. Platelet-activating factor is a potent stimulus for renal prostaglandin synthesis: possible significance in unilateral ureteral obstruction.
    Weisman SM, Felsen D, Vaughan ED.
    J Pharmacol Exp Ther; 1985 Oct; 235(1):10-5. PubMed ID: 3862805
    [Abstract] [Full Text] [Related]

  • 11. Mepyramine inhibits platelet activating factor-induced rabbit platelet aggregation: role of intracellular histamine.
    Zeng S, Guo ZG.
    Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):155-8. PubMed ID: 10072970
    [Abstract] [Full Text] [Related]

  • 12. Histamine release from rabbit platelets by platelet-activating factor (PAF).
    Nakahodo K, Saitoh S, Nakamura M, Kosugi T.
    Arerugi; 1994 Mar; 43(3):501-10. PubMed ID: 7515227
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Relation of platelet activating factor induced airway hyperresponsiveness to thromboxane A2 and neutrophil in dogs].
    Imai T, Adachi M, Horikoshi S, Sugeta A, Idaira K, Takahashi T, Tanaka Y.
    Arerugi; 1993 Oct; 42(10):1563-8. PubMed ID: 8250720
    [Abstract] [Full Text] [Related]

  • 17. Effect of systemic platelet-activating factor (PAF) on the rabbit spinal cord microcirculation.
    Lindsberg PJ, Jacobs TP, Paakkari IA, Hallenbeck JM, Feuerstein G.
    J Lipid Mediat; 1990 Oct; 2(1):41-58. PubMed ID: 2133267
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of Human Platelet Cytotoxicity by Various Activators in the Absence of Antibodies: Release of Thromboxane A2 and Soluble Cytotoxic Factors. Purification and Partial Characterisation of 14 and 28 kDa Cytotoxic Proteins.
    Paromov VM, Bughlava S, Malakhova NV, Kiselevsky MV, Dolgikh DA, Kirpichnikov MP.
    Russ J Immunol; 1998 Dec; 3(3-4):245-254. PubMed ID: 12687102
    [Abstract] [Full Text] [Related]

  • 19. Differential actions of naftopidil, doxazosin and nifedipine on platelet thromboxane generation and platelet-derived growth factor efflux in vitro.
    Alarayyed NA, Prichard BN, Betteridge DJ, Smith CC.
    Platelets; 2002 Dec; 13(5-6):267-71. PubMed ID: 12189011
    [Abstract] [Full Text] [Related]

  • 20. Synthesis of platelet-activating factor by human blood platelets and leucocytes. Evidence against selective utilization of cellular ether-linked phospholipids.
    Sturk A, Schaap MC, Prins A, ten Cate JW, van den Bosch H.
    Biochim Biophys Acta; 1989 Dec 08; 993(2-3):148-56. PubMed ID: 2512985
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.